Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge.

Region Region London, Greater London
  Country United Kingdom (GB)
Organisation Organisation Novacyt S.A. (Alternext: ALNOV)
  Group Novacyt (Group)
Products Product investment banking
  Product 2 LIFE SCIENCES
Index term Index term Novacyt–SEVERAL: investment, 201710 capital increase €9.7m with 14.74m new shares at €0.66/share
Persons Person Mullis, Graham (Novacyt 201409 CEO before Lab21 CEO)
  Person 2 Dyer, Anthony (Novacyt 201409– Finance Director before part time Group Financial Controller)
     


   
Record changed: 2017-10-30

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Novacyt (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px